PubMed:32376603 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":69},"obj":"Sentence"},{"id":"T2","span":{"begin":70,"end":244},"obj":"Sentence"},{"id":"T3","span":{"begin":245,"end":353},"obj":"Sentence"},{"id":"T4","span":{"begin":354,"end":440},"obj":"Sentence"},{"id":"T5","span":{"begin":441,"end":652},"obj":"Sentence"},{"id":"T6","span":{"begin":653,"end":798},"obj":"Sentence"},{"id":"T7","span":{"begin":799,"end":1028},"obj":"Sentence"},{"id":"T8","span":{"begin":1029,"end":1103},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2.\nThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are currently no SARS-CoV-2-specific treatments or vaccines available due to the novelty of the virus. Hence, rapid development of effective vaccines against SARS-CoV-2 are urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies neutralized 10 representative SARS-CoV-2 strains, suggesting a possible broader neutralizing ability against SARS-CoV-2 strains. Three immunizations using two different doses (3 μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without observable antibody-dependent enhancement of infection. These data support clinical development of SARS-CoV-2 vaccines for humans."}

{"project":"Covid19_manual_annotation_v2","denotations":[{"id":"T1","span":{"begin":100,"end":108},"obj":"Disease"},{"id":"T10","span":{"begin":700,"end":710},"obj":"Species"},{"id":"T11","span":{"begin":779,"end":789},"obj":"Species"},{"id":"T13","span":{"begin":129,"end":176},"obj":"Species"},{"id":"T14","span":{"begin":36,"end":43},"obj":"Chemical"},{"id":"T15","span":{"begin":302,"end":310},"obj":"Chemical"},{"id":"T16","span":{"begin":392,"end":400},"obj":"Chemical"},{"id":"T17","span":{"begin":527,"end":534},"obj":"Chemical"},{"id":"T18","span":{"begin":1072,"end":1091},"obj":"Chemical"},{"id":"T19","span":{"begin":110,"end":118},"obj":"Outbreak"},{"id":"T2","span":{"begin":74,"end":98},"obj":"Disease"},{"id":"T20","span":{"begin":332,"end":352},"obj":"Species"},{"id":"T21","span":{"begin":498,"end":509},"obj":"Chemical"},{"id":"T23","span":{"begin":546,"end":554},"obj":"Chemical"},{"id":"T24","span":{"begin":618,"end":622},"obj":"Species"},{"id":"T25","span":{"begin":624,"end":628},"obj":"Species"},{"id":"T26","span":{"begin":633,"end":651},"obj":"Species"},{"id":"T27","span":{"begin":563,"end":570},"obj":"PositiveRegulation"},{"id":"T28","span":{"begin":591,"end":614},"obj":"Gene"},{"id":"T29","span":{"begin":846,"end":847},"obj":"Number"},{"id":"T3","span":{"begin":929,"end":939},"obj":"Species"},{"id":"T30","span":{"begin":854,"end":855},"obj":"Number"},{"id":"T31","span":{"begin":912,"end":920},"obj":"Species"},{"id":"T32","span":{"begin":1018,"end":1027},"obj":"Disease"},{"id":"T33","span":{"begin":1003,"end":1014},"obj":"PositiveRegulation"},{"id":"T34","span":{"begin":965,"end":972},"obj":"Without"},{"id":"T35","span":{"begin":898,"end":908},"obj":"Inhibition"},{"id":"T36","span":{"begin":878,"end":885},"obj":"Condition"},{"id":"T37","span":{"begin":889,"end":897},"obj":"Condition"},{"id":"T38","span":{"begin":898,"end":908},"obj":"Inhibition"},{"id":"T39","span":{"begin":799,"end":804},"obj":"Number"},{"id":"T4","span":{"begin":58,"end":68},"obj":"Chemical"},{"id":"T40","span":{"begin":839,"end":844},"obj":"Dose"},{"id":"T41","span":{"begin":839,"end":844},"obj":"Dose"},{"id":"T42","span":{"begin":682,"end":684},"obj":"Number"},{"id":"T43","span":{"begin":711,"end":718},"obj":"Unit"},{"id":"T44","span":{"begin":670,"end":681},"obj":"Inhibition"},{"id":"T45","span":{"begin":653,"end":669},"obj":"Gene"},{"id":"T46","span":{"begin":527,"end":534},"obj":"Chemical"},{"id":"T47","span":{"begin":24,"end":43},"obj":"Chemical"},{"id":"T48","span":{"begin":848,"end":850},"obj":"Unit"},{"id":"T49","span":{"begin":856,"end":858},"obj":"Unit"},{"id":"T5","span":{"begin":178,"end":188},"obj":"Species"},{"id":"T50","span":{"begin":685,"end":699},"obj":"Type"},{"id":"T51","span":{"begin":805,"end":818},"obj":"Unit"},{"id":"T52","span":{"begin":912,"end":920},"obj":"Species"},{"id":"T6","span":{"begin":268,"end":278},"obj":"Species"},{"id":"T7","span":{"begin":409,"end":419},"obj":"Chemical"},{"id":"T8","span":{"begin":510,"end":520},"obj":"Chemical"},{"id":"T9","span":{"begin":571,"end":581},"obj":"Species"},{"id":"T53","span":{"begin":288,"end":298},"obj":"Therapy"},{"id":"T54","span":{"begin":265,"end":267},"obj":"Without"},{"id":"T55","span":{"begin":268,"end":278},"obj":"Chemical"},{"id":"T56","span":{"begin":268,"end":278},"obj":"Therapy"}],"relations":[{"id":"R54","pred":"associate_with","subj":"T39","obj":"T51"},{"id":"R55","pred":"to","subj":"T41","obj":"T52"},{"id":"R56","pred":"to","subj":"T40","obj":"T31"},{"id":"R59","pred":"associate_with","subj":"T39","obj":"T29"},{"id":"R60","pred":"associate_with","subj":"T39","obj":"T30"},{"id":"R61","pred":"with","subj":"T23","obj":"T41"},{"id":"R62","pred":"with","subj":"T23","obj":"T40"},{"id":"R63","pred":"is_a","subj":"T54","obj":"T55"},{"id":"R64","pred":"is_a","subj":"T54","obj":"T56"},{"id":"R65","pred":"-","subj":"T55","obj":"T15"},{"id":"R66","pred":"-","subj":"T56","obj":"T53"},{"id":"R46","pred":"-","subj":"T16","obj":"T7"},{"id":"R1","pred":"abbreviation","subj":"T1","obj":"T2"},{"id":"R13","pred":"named","subj":"T23","obj":"T17"},{"id":"R14","pred":"is_a","subj":"T17","obj":"T27"},{"id":"R15","pred":"is_a","subj":"T27","obj":"T28"},{"id":"R16","pred":"against","subj":"T9","obj":"T28"},{"id":"R17","pred":"in","subj":"T24","obj":"T28"},{"id":"R18","pred":"in","subj":"T25","obj":"T28"},{"id":"R19","pred":"in","subj":"T26","obj":"T28"},{"id":"R2","pred":"abbreviation","subj":"T5","obj":"T13"},{"id":"R20","pred":"associate_with","subj":"T29","obj":"T40"},{"id":"R21","pred":"associate_with","subj":"T30","obj":"T41"},{"id":"R24","pred":"has_role","subj":"T40","obj":"T35"},{"id":"R28","pred":"has_status","subj":"T35","obj":"T36"},{"id":"R29","pred":"has_status","subj":"T38","obj":"T37"},{"id":"R3","pred":"coreference","subj":"T20","obj":"T6"},{"id":"R30","pred":"has_role","subj":"T41","obj":"T38"},{"id":"R32","pred":"is_a","subj":"T34","obj":"T33"},{"id":"R33","pred":"is_a","subj":"T33","obj":"T32"},{"id":"R34","pred":"of_a","subj":"T34","obj":"T38"},{"id":"R35","pred":"of_a","subj":"T34","obj":"T35"},{"id":"R36","pred":"associate_with","subj":"T42","obj":"T43"},{"id":"R37","pred":"coreference","subj":"T45","obj":"T28"},{"id":"R38","pred":"has_role","subj":"T45","obj":"T44"},{"id":"R4","pred":"cause_of","subj":"T13","obj":"T19"},{"id":"R41","pred":"-","subj":"T21","obj":"T17"},{"id":"R42","pred":"-","subj":"T8","obj":"T46"},{"id":"R43","pred":"named","subj":"T23","obj":"T46"},{"id":"R44","pred":"is_a","subj":"T46","obj":"T27"},{"id":"R45","pred":"-","subj":"T14","obj":"T4"},{"id":"R47","pred":"against","subj":"T44","obj":"T10"},{"id":"R48","pred":"against","subj":"T35","obj":"T3"},{"id":"R49","pred":"against","subj":"T38","obj":"T3"},{"id":"R5","pred":"cause_of","subj":"T13","obj":"T2"},{"id":"R50","pred":"associate_with","subj":"T48","obj":"T29"},{"id":"R51","pred":"associate_with","subj":"T49","obj":"T30"},{"id":"R52","pred":"associate_with","subj":"T42","obj":"T10"},{"id":"R53","pred":"of_a","subj":"T50","obj":"T43"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"T21","obj":"MESH:D015164"},{"id":"A34","pred":"ForCovid19","subj":"T21","obj":"drug"},{"id":"A17","pred":"ForCovid19","subj":"T17","obj":"drug"},{"id":"A32","pred":"tao:has_database_id","subj":"T17","obj":"MESH:D015164"},{"id":"A38","pred":"tao:has_database_id","subj":"T47","obj":"MESH:D015164"},{"id":"A39","pred":"ForCovid19","subj":"T47","obj":"drug"},{"id":"A37","pred":"tao:has_database_id","subj":"T26","obj":"Tax:9443"},{"id":"A1","pred":"tao:has_database_id","subj":"T1","obj":"MESH:C000657245"},{"id":"A2245","pred":"tao:has_database_id","subj":"T45","obj":"MESH:D057134"},{"id":"A15","pred":"ForCovid19","subj":"T15","obj":"drug"},{"id":"A30","pred":"tao:has_database_id","subj":"T15","obj":"MESH:D000086663"},{"id":"A4","pred":"tao:has_database_id","subj":"T4","obj":"MESH:D000086663"},{"id":"A40","pred":"ForCovid19","subj":"T4","obj":"drug"},{"id":"A25","pred":"tao:has_database_id","subj":"T28","obj":"MESH:D057134"},{"id":"A23","pred":"tao:has_database_id","subj":"T24","obj":"Tax:10090"},{"id":"A14","pred":"ForCovid19","subj":"T14","obj":"drug"},{"id":"A29","pred":"tao:has_database_id","subj":"T14","obj":"MESH:D000086663"},{"id":"A9","pred":"tao:has_database_id","subj":"T9","obj":"Tax:2697049"},{"id":"A2248","pred":"tao:has_database_id","subj":"T55","obj":"MESH:D000086663"},{"id":"A2249","pred":"ForCovid19","subj":"T55","obj":"drug"},{"id":"A27","pred":"tao:has_database_id","subj":"T32","obj":"MESH:D007239"},{"id":"A24","pred":"tao:has_database_id","subj":"T25","obj":"Tax:10116"},{"id":"A2243","pred":"tao:has_database_id","subj":"T52","obj":"Tax:9539"},{"id":"A19","pred":"tao:has_database_id","subj":"T19","obj":"MESH:D058873"},{"id":"A10","pred":"tao:has_database_id","subj":"T10","obj":"Tax:2697049"},{"id":"A11","pred":"tao:has_database_id","subj":"T11","obj":"Tax:2697049"},{"id":"A26","pred":"tao:has_database_id","subj":"T31","obj":"Tax:9539"},{"id":"A5","pred":"tao:has_database_id","subj":"T5","obj":"Tax:2697049"},{"id":"A2","pred":"tao:has_database_id","subj":"T2","obj":"MESH:C000657245"},{"id":"A16","pred":"ForCovid19","subj":"T16","obj":"drug"},{"id":"A31","pred":"tao:has_database_id","subj":"T16","obj":"MESH:D000086663"},{"id":"A22","pred":"ForCovid19","subj":"T23","obj":"drug"},{"id":"A2246","pred":"tao:has_database_id","subj":"T23","obj":"MESH:D015164"},{"id":"A2247","pred":"tao:has_database_id","subj":"T23","obj":"MESH:D000086663"},{"id":"A3","pred":"tao:has_database_id","subj":"T3","obj":"Tax:2697049"},{"id":"A42","pred":"ForCovid19","subj":"T8","obj":"drug"},{"id":"A8","pred":"tao:has_database_id","subj":"T8","obj":"MESH:D000086663"},{"id":"A41","pred":"ForCovid19","subj":"T7","obj":"drug"},{"id":"A7","pred":"tao:has_database_id","subj":"T7","obj":"MESH:D000086663"},{"id":"A35","pred":"tao:has_database_id","subj":"T46","obj":"MESH:D000086663"},{"id":"A36","pred":"ForCovid19","subj":"T46","obj":"drug"},{"id":"A20","pred":"tao:has_database_id","subj":"T20","obj":"Tax:2697049"},{"id":"A6","pred":"tao:has_database_id","subj":"T6","obj":"Tax:2697049"},{"id":"A18","pred":"ForCovid19","subj":"T18","obj":"drug"},{"id":"A28","pred":"tao:has_database_id","subj":"T18","obj":"MESH:D000086663"},{"id":"A13","pred":"tao:has_database_id","subj":"T13","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"BioProject","uri":"https://www.ncbi.nlm.nih.gov/bioproject/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"},{"prefix":"HP","uri":"https://hpo.jax.org/app/browse/term/HP:"},{"prefix":"BioSample","uri":"https://www.ncbi.nlm.nih.gov/biosample/"}],"text":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2.\nThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are currently no SARS-CoV-2-specific treatments or vaccines available due to the novelty of the virus. Hence, rapid development of effective vaccines against SARS-CoV-2 are urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies neutralized 10 representative SARS-CoV-2 strains, suggesting a possible broader neutralizing ability against SARS-CoV-2 strains. Three immunizations using two different doses (3 μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without observable antibody-dependent enhancement of infection. These data support clinical development of SARS-CoV-2 vaccines for humans."}

{"project":"Zoonoses","denotations":[{"id":"T1","span":{"begin":100,"end":108},"obj":"Disease"},{"id":"T10","span":{"begin":700,"end":710},"obj":"Species"},{"id":"T11","span":{"begin":779,"end":789},"obj":"Species"},{"id":"T13","span":{"begin":129,"end":176},"obj":"Species"},{"id":"T14","span":{"begin":36,"end":43},"obj":"Chemical"},{"id":"T16","span":{"begin":392,"end":400},"obj":"Chemical"},{"id":"T17","span":{"begin":527,"end":534},"obj":"Chemical"},{"id":"T18","span":{"begin":1072,"end":1091},"obj":"Chemical"},{"id":"T19","span":{"begin":110,"end":118},"obj":"Outbreak"},{"id":"T2","span":{"begin":74,"end":98},"obj":"Disease"},{"id":"T21","span":{"begin":498,"end":509},"obj":"Chemical"},{"id":"T23","span":{"begin":546,"end":554},"obj":"Chemical"},{"id":"T24","span":{"begin":618,"end":622},"obj":"Species"},{"id":"T25","span":{"begin":624,"end":628},"obj":"Species"},{"id":"T26","span":{"begin":633,"end":651},"obj":"Species"},{"id":"T27","span":{"begin":563,"end":570},"obj":"PositiveRegulation"},{"id":"T28","span":{"begin":591,"end":614},"obj":"Gene"},{"id":"T29","span":{"begin":846,"end":847},"obj":"Number"},{"id":"T3","span":{"begin":929,"end":939},"obj":"Species"},{"id":"T30","span":{"begin":854,"end":855},"obj":"Number"},{"id":"T31","span":{"begin":912,"end":920},"obj":"Species"},{"id":"T32","span":{"begin":1018,"end":1027},"obj":"Disease"},{"id":"T33","span":{"begin":1003,"end":1014},"obj":"PositiveRegulation"},{"id":"T34","span":{"begin":965,"end":972},"obj":"Without"},{"id":"T35","span":{"begin":898,"end":908},"obj":"Inhibition"},{"id":"T36","span":{"begin":878,"end":885},"obj":"Condition"},{"id":"T37","span":{"begin":889,"end":897},"obj":"Condition"},{"id":"T38","span":{"begin":898,"end":908},"obj":"Inhibition"},{"id":"T39","span":{"begin":799,"end":804},"obj":"Number"},{"id":"T15","span":{"begin":302,"end":310},"obj":"Chemical"},{"id":"T20","span":{"begin":332,"end":352},"obj":"Species"},{"id":"T53","span":{"begin":288,"end":298},"obj":"Therapy"},{"id":"T54","span":{"begin":265,"end":267},"obj":"Without"},{"id":"T55","span":{"begin":268,"end":278},"obj":"Chemical"},{"id":"T6","span":{"begin":268,"end":278},"obj":"Species"},{"id":"T4","span":{"begin":58,"end":68},"obj":"Chemical"},{"id":"T40","span":{"begin":839,"end":844},"obj":"Dose"},{"id":"T41","span":{"begin":839,"end":844},"obj":"Dose"},{"id":"T42","span":{"begin":682,"end":684},"obj":"Number"},{"id":"T43","span":{"begin":711,"end":718},"obj":"Unit"},{"id":"T44","span":{"begin":670,"end":681},"obj":"Inhibition"},{"id":"T45","span":{"begin":653,"end":669},"obj":"Gene"},{"id":"T46","span":{"begin":527,"end":534},"obj":"Chemical"},{"id":"T47","span":{"begin":24,"end":43},"obj":"Chemical"},{"id":"T48","span":{"begin":848,"end":850},"obj":"Unit"},{"id":"T49","span":{"begin":856,"end":858},"obj":"Unit"},{"id":"T5","span":{"begin":178,"end":188},"obj":"Species"},{"id":"T50","span":{"begin":685,"end":699},"obj":"Type"},{"id":"T51","span":{"begin":805,"end":818},"obj":"Unit"},{"id":"T52","span":{"begin":912,"end":920},"obj":"Species"},{"id":"T7","span":{"begin":409,"end":419},"obj":"Chemical"},{"id":"T8","span":{"begin":510,"end":520},"obj":"Chemical"},{"id":"T9","span":{"begin":571,"end":581},"obj":"Species"}],"relations":[{"id":"R1","pred":"abbreviation","subj":"T1","obj":"T2"},{"id":"R13","pred":"named","subj":"T23","obj":"T17"},{"id":"R14","pred":"is_a","subj":"T17","obj":"T27"},{"id":"R15","pred":"is_a","subj":"T27","obj":"T28"},{"id":"R16","pred":"against","subj":"T9","obj":"T28"},{"id":"R17","pred":"in","subj":"T24","obj":"T28"},{"id":"R18","pred":"in","subj":"T25","obj":"T28"},{"id":"R19","pred":"in","subj":"T26","obj":"T28"},{"id":"R2","pred":"abbreviation","subj":"T5","obj":"T13"},{"id":"R20","pred":"associate_with","subj":"T29","obj":"T40"},{"id":"R21","pred":"associate_with","subj":"T30","obj":"T41"},{"id":"R24","pred":"has_role","subj":"T40","obj":"T35"},{"id":"R28","pred":"has_status","subj":"T35","obj":"T36"},{"id":"R29","pred":"has_status","subj":"T38","obj":"T37"},{"id":"R30","pred":"has_role","subj":"T41","obj":"T38"},{"id":"R32","pred":"is_a","subj":"T34","obj":"T33"},{"id":"R33","pred":"is_a","subj":"T33","obj":"T32"},{"id":"R34","pred":"of_a","subj":"T34","obj":"T38"},{"id":"R35","pred":"of_a","subj":"T34","obj":"T35"},{"id":"R36","pred":"associate_with","subj":"T42","obj":"T43"},{"id":"R37","pred":"coreference","subj":"T45","obj":"T28"},{"id":"R38","pred":"has_role","subj":"T45","obj":"T44"},{"id":"R4","pred":"cause_of","subj":"T13","obj":"T19"},{"id":"R41","pred":"-","subj":"T21","obj":"T17"},{"id":"R42","pred":"-","subj":"T8","obj":"T46"},{"id":"R43","pred":"named","subj":"T23","obj":"T46"},{"id":"R44","pred":"is_a","subj":"T46","obj":"T27"},{"id":"R45","pred":"-","subj":"T14","obj":"T4"},{"id":"R46","pred":"-","subj":"T16","obj":"T7"},{"id":"R47","pred":"against","subj":"T44","obj":"T10"},{"id":"R48","pred":"against","subj":"T35","obj":"T3"},{"id":"R54","pred":"associate_with","subj":"T39","obj":"T51"},{"id":"R55","pred":"to","subj":"T41","obj":"T52"},{"id":"R56","pred":"to","subj":"T40","obj":"T31"},{"id":"R59","pred":"associate_with","subj":"T39","obj":"T29"},{"id":"R60","pred":"associate_with","subj":"T39","obj":"T30"},{"id":"R61","pred":"with","subj":"T23","obj":"T41"},{"id":"R62","pred":"with","subj":"T23","obj":"T40"},{"id":"R63","pred":"is_a","subj":"T54","obj":"T55"},{"id":"R65","pred":"-","subj":"T55","obj":"T15"},{"id":"R66","pred":"is_a","subj":"T54","obj":"T53"},{"id":"R67","pred":"for","subj":"T53","obj":"T6"},{"id":"R3","pred":"coreference","subj":"T20","obj":"T6"},{"id":"R49","pred":"against","subj":"T38","obj":"T3"},{"id":"R5","pred":"cause_of","subj":"T13","obj":"T2"},{"id":"R50","pred":"associate_with","subj":"T48","obj":"T29"},{"id":"R51","pred":"associate_with","subj":"T49","obj":"T30"},{"id":"R52","pred":"associate_with","subj":"T42","obj":"T10"},{"id":"R53","pred":"of_a","subj":"T50","obj":"T43"}],"attributes":[{"id":"A24","pred":"tao:has_database_id","subj":"T25","obj":"Tax:10116"},{"id":"A1","pred":"tao:has_database_id","subj":"T1","obj":"MESH:D000086382"},{"id":"A6","pred":"tao:has_database_id","subj":"T6","obj":"Tax:2697049"},{"id":"A2248","pred":"tao:has_database_id","subj":"T55","obj":"MESH:D000086663"},{"id":"A2253","pred":"ForZoonoses","subj":"T55","obj":"drug"},{"id":"A2260","pred":"ForZoonoses","subj":"T46","obj":"drug"},{"id":"A23","pred":"tao:has_database_id","subj":"T24","obj":"Tax:10090"},{"id":"A35","pred":"tao:has_database_id","subj":"T46","obj":"MESH:D000086663"},{"id":"A2252","pred":"ForZoonoses","subj":"T4","obj":"drug"},{"id":"A4","pred":"tao:has_database_id","subj":"T4","obj":"MESH:D000086663"},{"id":"A2254","pred":"ForZoonoses","subj":"T16","obj":"drug"},{"id":"A31","pred":"tao:has_database_id","subj":"T16","obj":"MESH:D000086663"},{"id":"A5","pred":"tao:has_database_id","subj":"T5","obj":"Tax:2697049"},{"id":"A2255","pred":"ForZoonoses","subj":"T7","obj":"drug"},{"id":"A7","pred":"tao:has_database_id","subj":"T7","obj":"MESH:D000086663"},{"id":"A2250","pred":"ForZoonoses","subj":"T47","obj":"drug"},{"id":"A38","pred":"tao:has_database_id","subj":"T47","obj":"MESH:D015164"},{"id":"A13","pred":"tao:has_database_id","subj":"T13","obj":"Tax:2697049"},{"id":"A27","pred":"tao:has_database_id","subj":"T32","obj":"MESH:D007239"},{"id":"A2257","pred":"ForZoonoses","subj":"T21","obj":"drug"},{"id":"A33","pred":"tao:has_database_id","subj":"T21","obj":"MESH:D015164"},{"id":"A20","pred":"tao:has_database_id","subj":"T20","obj":"Tax:2697049"},{"id":"A2262","pred":"ForZoonoses","subj":"T18","obj":"drug"},{"id":"A28","pred":"tao:has_database_id","subj":"T18","obj":"MESH:D000086663"},{"id":"A2245","pred":"tao:has_database_id","subj":"T45","obj":"MESH:D057134"},{"id":"A2246","pred":"tao:has_database_id","subj":"T23","obj":"MESH:D015164"},{"id":"A2247","pred":"tao:has_database_id","subj":"T23","obj":"MESH:D000086663"},{"id":"A2251","pred":"ForZoonoses","subj":"T14","obj":"drug"},{"id":"A2261","pred":"ForZoonoses","subj":"T23","obj":"drug"},{"id":"A29","pred":"tao:has_database_id","subj":"T14","obj":"MESH:D000086663"},{"id":"A9","pred":"tao:has_database_id","subj":"T9","obj":"Tax:2697049"},{"id":"A26","pred":"tao:has_database_id","subj":"T31","obj":"Tax:9539"},{"id":"A10","pred":"tao:has_database_id","subj":"T10","obj":"Tax:2697049"},{"id":"A25","pred":"tao:has_database_id","subj":"T28","obj":"MESH:D057134"},{"id":"A2243","pred":"tao:has_database_id","subj":"T52","obj":"Tax:9539"},{"id":"A11","pred":"tao:has_database_id","subj":"T11","obj":"Tax:2697049"},{"id":"A37","pred":"tao:has_database_id","subj":"T26","obj":"Tax:9443"},{"id":"A3","pred":"tao:has_database_id","subj":"T3","obj":"Tax:2697049"},{"id":"A2256","pred":"ForZoonoses","subj":"T15","obj":"drug"},{"id":"A30","pred":"tao:has_database_id","subj":"T15","obj":"MESH:D000086663"},{"id":"A2","pred":"tao:has_database_id","subj":"T2","obj":"MESH:D000086382"},{"id":"A2259","pred":"ForZoonoses","subj":"T8","obj":"drug"},{"id":"A8","pred":"tao:has_database_id","subj":"T8","obj":"MESH:D000086663"},{"id":"A19","pred":"tao:has_database_id","subj":"T19","obj":"MESH:D058873"},{"id":"A2258","pred":"ForZoonoses","subj":"T17","obj":"drug"},{"id":"A32","pred":"tao:has_database_id","subj":"T17","obj":"MESH:D015164"}],"text":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2.\nThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are currently no SARS-CoV-2-specific treatments or vaccines available due to the novelty of the virus. Hence, rapid development of effective vaccines against SARS-CoV-2 are urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies neutralized 10 representative SARS-CoV-2 strains, suggesting a possible broader neutralizing ability against SARS-CoV-2 strains. Three immunizations using two different doses (3 μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without observable antibody-dependent enhancement of infection. These data support clinical development of SARS-CoV-2 vaccines for humans."}

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":58,"end":68},"obj":"SP_7"},{"id":"T2","span":{"begin":74,"end":85},"obj":"NCBITaxon:11118"},{"id":"T3","span":{"begin":100,"end":108},"obj":"SP_7"},{"id":"T4","span":{"begin":129,"end":141},"obj":"SP_7"},{"id":"T5","span":{"begin":142,"end":153},"obj":"SP_7;UBERON:0001004"},{"id":"T6","span":{"begin":154,"end":176},"obj":"SP_7"},{"id":"T7","span":{"begin":178,"end":188},"obj":"SP_7"},{"id":"T8","span":{"begin":268,"end":278},"obj":"SP_7"},{"id":"T9","span":{"begin":347,"end":352},"obj":"NCBITaxon:10239"},{"id":"T10","span":{"begin":409,"end":419},"obj":"SP_7"},{"id":"T11","span":{"begin":510,"end":520},"obj":"SP_7"},{"id":"T12","span":{"begin":521,"end":526},"obj":"NCBITaxon:10239"},{"id":"T13","span":{"begin":571,"end":581},"obj":"SP_7"},{"id":"T14","span":{"begin":604,"end":614},"obj":"GO:0042571"},{"id":"T15","span":{"begin":618,"end":622},"obj":"NCBITaxon:10088"},{"id":"T16","span":{"begin":624,"end":628},"obj":"NCBITaxon:10114"},{"id":"T17","span":{"begin":637,"end":642},"obj":"SP_6;NCBITaxon:9606"},{"id":"T18","span":{"begin":643,"end":651},"obj":"NCBITaxon:9443"},{"id":"T19","span":{"begin":659,"end":669},"obj":"GO:0042571"},{"id":"T20","span":{"begin":700,"end":710},"obj":"SP_7"},{"id":"T21","span":{"begin":779,"end":789},"obj":"SP_7"},{"id":"T22","span":{"begin":912,"end":920},"obj":"NCBITaxon:9539"},{"id":"T23","span":{"begin":929,"end":939},"obj":"SP_7"},{"id":"T24","span":{"begin":984,"end":992},"obj":"GO:0042571"},{"id":"T25","span":{"begin":1072,"end":1082},"obj":"SP_7"},{"id":"T26","span":{"begin":1096,"end":1102},"obj":"NCBITaxon:9606"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Rapid development of an inactivated vaccine candidate for SARS-CoV-2.\nThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are currently no SARS-CoV-2-specific treatments or vaccines available due to the novelty of the virus. Hence, rapid development of effective vaccines against SARS-CoV-2 are urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies neutralized 10 representative SARS-CoV-2 strains, suggesting a possible broader neutralizing ability against SARS-CoV-2 strains. Three immunizations using two different doses (3 μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without observable antibody-dependent enhancement of infection. These data support clinical development of SARS-CoV-2 vaccines for humans."}